It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Endothelial erosion of atherosclerotic plaques is the underlying cause of approximately 30% of acute coronary syndromes (ACS). As the vascular endothelium is profoundly affected by the haemodynamic environment to which it is exposed, we employed computational fluid dynamic (CFD) analysis of the luminal geometry from 17 patients with optical coherence tomography (OCT)-defined plaque erosion, to determine the flow environment permissive for plaque erosion. Our results demonstrate that 15 of the 17 cases analysed occurred on stenotic plaques with median 31% diameter stenosis (interquartile range 28–52%), where all but one of the adherent thrombi located proximal to, or within the region of maximum stenosis. Consequently, all flow metrics related to elevated flow were significantly increased (time averaged wall shear stress, maximum wall shear stress, time averaged wall shear stress gradient) with a reduction in relative residence time, compared to a non-diseased reference segment. We also identified two cases that did not exhibit an elevation of flow, but occurred in a region exposed to elevated oscillatory flow. Our study demonstrates that the majority of OCT-defined erosions occur where the endothelium is exposed to elevated flow, a haemodynamic environment known to evoke a distinctive phenotypic response in endothelial cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 The University of Manchester, Department of Mechanical, Aerospace and Civil Engineering (MACE), Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407)
2 Yonsei University College of Medicine and Cardiovascular Center, Yongin Severance Hospital, Division of Cardiology, Department of Internal Medicine, Yongin, Republic of Korea (GRID:grid.5379.8)
3 University of Parma, Division of Cardiology, Department of Medicine and Surgery, Parma, Italy (GRID:grid.10383.39) (ISNI:0000 0004 1758 0937)
4 Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy (GRID:grid.414603.4); Universita’ Cattolica del Sacro Cuore, Rome, Italy (GRID:grid.8142.f) (ISNI:0000 0001 0941 3192)
5 Manchester Metropolitan University, Department of Life Sciences, Manchester, UK (GRID:grid.25627.34) (ISNI:0000 0001 0790 5329)
6 Erasmus Medical Centre, Department of Cardiology, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X); TUDelft, Department of Biomechanical Engineering, Delft, The Netherlands (GRID:grid.5292.c) (ISNI:0000 0001 2097 4740)
7 University Hospitals Bristol and Weston NHS Foundation Trust, Department of Cardiology, Bristol Heart Institute, Bristol, UK (GRID:grid.410421.2) (ISNI:0000 0004 0380 7336)